Pharmaceutical Investing Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
Medical Device Investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
Pharmaceutical Investing VistaGen Therapeutics Receives European Patent regarding Methods of Production for AV-101
Pharmaceutical Investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
